
Sign up to save your podcasts
Or


Alcoa kicks off earnings season, but it’s biotech Illumina that in the spotlight (and not for good reasons). Bill Barker and Bill Mann from Motley Fool Funds discuss those stories plus Samsung’s decision to kill the Galaxy Note 7, Warren Buffett’s response to Donald Trump, a couple of tangents and more.
By The Motley Fool4.7
16041,604 ratings
Alcoa kicks off earnings season, but it’s biotech Illumina that in the spotlight (and not for good reasons). Bill Barker and Bill Mann from Motley Fool Funds discuss those stories plus Samsung’s decision to kill the Galaxy Note 7, Warren Buffett’s response to Donald Trump, a couple of tangents and more.

3,241 Listeners

1,501 Listeners

806 Listeners

944 Listeners

529 Listeners

1,189 Listeners

2,185 Listeners

825 Listeners

1,426 Listeners

1,053 Listeners

9,716 Listeners

194 Listeners

827 Listeners

83 Listeners

50 Listeners

1,034 Listeners

50 Listeners